Follow-The-Filings

Security · featured owners

BOLT Bolt Biotherapeutics Inc.

Health Care COM NEW Equity among managers we track

BOLT (Bolt Biotherapeutics Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
10-Q
DEFA14A
8-K 2.02,9.01
10-K
8-K 2.02,9.01
10-Q
8-K 2.05,8.01
8-K 2.02,9.01
10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Sep 16, 2026 · 3 forms
4 Period Jun 10, 2026 · 5 forms
4 Period Jan 28, 2026 · 3 forms
4 Period Dec 12, 2025 · 8 forms
4 Period Oct 24, 2025 · 3 forms
4 Period May 27, 2025 · 3 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $7.88M $7.69M $7.7M
Net income -$69.2M -$63.12M -$33.38M
Net margin * -878.6% -820.8% -433.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $105.71M $50.81M $30.26M
Total non-current assets * $54.08M $48.82M $26.49M
Total assets $159.78M $99.63M $56.75M
Total current liabilities $20.46M $15.86M $8.44M
Total non-current liabilities * $26.59M $26.58M $21.81M
Total equity $112.74M $57.2M $26.5M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$69.52M -$61.29M -$39.85M
Cash from investing $71.04M $57.58M $44.3M
Cash from financing $253,000 $108,000 $19,000
Net change in cash $1.77M -$3.6M $4.47M

ownership over time

filing count by report period · click a bar for that quarter’s holders